Reversibility of serum NH3 level in a case of sudden onset and rapidly progressive case of type 2 citrullinemia

Internal Medicine

Volumn 39, Issue 11, 2000, Pages 925-929

  Ishikawa, Fumihiko ^b   Nakamuta, Makoto ^b   Kato, Masaki ^b   Iwamoto, Hiroaki ^b   Enjoji, Munechika ^b   Miyata, Yasuji ^a   Inoguchi, Toyoshi ^b   Sakai, Hironori ^b   Nawata, Hajime ^b  

^a Miyata Medical Clinic   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Argininosuccinate synthetase; Brain edema; Citrin; Hemodiafiltration; Hemodialysis

Indexed keywords

AMMONIA;

ARTICLE; BLOOD; CASE REPORT; CITRULLINEMIA; CLASSIFICATION; DISEASE COURSE; HUMAN; MALE; MIDDLE AGED; TIME;

AMMONIA; CITRULLINEMIA; DISEASE PROGRESSION; HUMANS; MALE; MIDDLE AGED; TIME FACTORS;

EID: 0034329775     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.39.925     Document Type: Article

References (28)

1. Saheki T, Ueda A, Hosoya M, et al. Qualitative and quantitative abnormalities of argininosuccinate synthetase in citrullinemia. Clin Chim Acta 109: 325-335, 1981.
2. Saheki T, Ueda A, Iizima K, et al. Argininosuccinate synthetase activity in cultured skin fibroblasts of citrullinemia. Clin Chim Acta 118: 93-97, 1982.
3. Saheki T, Ueda A, Hosoya M, et al. Enzymatic analysis of citrullinemia (12 cases) in Japan. Adv Exp Med Biol 153: 63-76, 1983.
4. Saheki T, Sase M, Nakano K, Yagi Y. Arginine metabolism in citrullinemic patients, in: Guanidines, Mori A, Cohen BD, Lowenthal A, Eds. Plenum, New York, 1985: 149-158.
5. Sase M, Kobayashi K, Imamura Y, et al. Level of translatable messenger RNA coding for argininosuccinate synthetase in the liver of the patients with quantitative-type citrullinemia. Hum Genet 69: 130-134, 1985.
6. Kobayashi K, Saheki T, Imamura Y, et al. Messenger RNA coding for argininosuccinate synthetase in cirullinemia. Am J Hum Gent 38: 667-680, 1986.
7. Saheki T, Kobayashi K, Inoue I, et al. Serum amino acid pattern of type II citrullinemic patients and effect of oral administration of citrulline. J Clin Biochem Nutr 1: 129-142, 1986.
8. Saheki T, Kobayashi K, Inoue I, Matuo S, Hagihara S, Noda T. Increased urinary excretion of argininosuccinate in type II citrullinemia. Clin Chim Acta 170: 297-304, 1987.
9. Imamura Y, Kobayashi K, Yamashita T, et al. Clinical application of enzyme immunoassay in the analysis of citrullinemia. Clin Chim Acta 164: 201-208, 1987.
10. Saheki T, Kobayashi K, Inoue I. Hereditary disorders of the urea cycle in man: biochemical and molecular approaches. Rev Physiol Biochem Pharmacol 108: 21-68, 1987.
11. Yagi Y, Saheki T, Imamura Y, et al. The heterogeneous distribution of argininosuccinate synthetase in the liver of type II citrullinemic patients: its specificity and possible clinical implications. Am J Clin Pathol 89: 735-741, 1988.
12. Kobayashi K, Shaheen N, Kumashino R, et al. A search for the primary abnormality in adult-onset type II citrullinemia. Am J Hum Genet 53: 1024-1030, 1993.
13. Kobayashi K, Nakata M, Terazono H, Shinsato T, Saheki T. Pancreatic secretory trypsin inhibitor gene is highly expressed in the liver of adult-onset type II citrullinemia. FEBS Lett 372: 69-73, 1995.
14. Kobayashi K, Horiuchi M, Saheki T. Pancreatic secretory trypsin inhibitor as a diagnostic marker for adult-onset type II cirullinemia. Hepatology 25: 1160-1165, 1997.
15. Kobayashi K, Jackson MJ, Tick DB, O'Brien WE, Beaudet AL. Heterogeneity of mutations in argininosuccinate synthetase causing human citrullinemia. J Biol Chem 265: 11361-11367, 1990.
16. Kobayashi K, Shaheen N, Terazono H, Saheki T. Mutations in argininosuccinate synthetase mRNA of Japanese patients, causing classical citrullinemia. Am J Hum Genet 55: 1103-1112, 1994 (published erratum appears in Am J Hum Genet 56: 356, 1995).
17. Kobayashi K, Kakinoki H, Fukushige T, Shaheen N, Terazono H, Saheki T. Nature and frequency of mutations in the argininosuccinate synthetase gene that cause classical citrullinemia. Hum Genet 96: 454-463, 1995.
18. Kakinoki H, Kobayashi K, Terazono H, Nagata Y, Saheki T. Mutations and DNA diagnosis of classical citrullinemia. Hum Mutat 9: 250-259, 1997.
19. Kobayashi K, Sinasac DS, Iijima M, et al. The gene mutated in adult-onset type II citrullinaemia encodes a putative mitochondrial carrier protein. Nature Genet 22: 159-163, 1999.
20. Ohta N, Saito T, Hayashi Y, Sakai N, Saito H, Hiroi M. A case of citrullinemia repeatedly induced by pregnancy. Acta Obstet Gynaecol Jpn 48: 351-354, 1996 (in Japanese).
21. Shiohama N, Sugita Y, Imamura N, SatoT, Mizuno Y. Type 2 citullinemia triggered by acetaminophen. Brain Nerve 45: 865-870, 1993 (in Japanese).
22. Ishii A, Ohkoshi N, Oka Y, et al. A case of citrullinemia associated with isolated ACTH deficiency, rapidly developing coma. Clin Neurol 32: 853-858, 1992 (in Japanese).
23. Osufune K, Ichikawa K, Yasui T, et al. An adult-onset case of argininosuccinate synthetase deficiency presenting with atypical citrullinemia. Intern Med 38: 590-596, 1999.
24. Todo S, Starzl TE, Tzakis A, et al. Orthotopic liver transplantation for urea cycle enzyme deficiency. Hepatology 15: 419-422, 1992.
25. Yazaki M, Ikeda S, Takei Y, et al. Complete neurological recovery of an adult patient with type 2 citrullinemia after living related partial liver transplantation. Transplantation 62: 1679-1684, 1996.
26. Kawata A, Suda M, Tanabe H. Adult onset type 2 cirullinemia : clinical pictures before and after liver transplantation. Intern Med 6: 408-412, 1997.
27. Saheki T, Kobayashi K, Ichiki H, et al. Molecular basis of enzyme abnormalities in urea cycle disorders. With special reference to citrullinemia and argininosuccinic aciduria. Enzyme 38: 227-232, 1987.
28. Demarquoy J. Retroviral-mediated gene therapy for the treatment of citrullinemia. Transfer and expression of argininosuccinate synthetase in human hematopoietic cells. Experientia 49: 345-348, 1993.